Parexel, NeoGenomics partner on oncology genomics project The two companies will work to advance precision cancer medicine by harnessing genomics data in trial design, recruitment, site selection and other areas Clinical services specialist Parexel has entered a strategic partnership with NeoGenomics, a cancer-centric genetic testing and research firm, with the intent to collaborate on ways to use genomics data to improve clinical trials and drug development. The collaboration will seek out ways to advance precision medicine in oncology clinical trials through the application of real-world genomic data to improve patient matching, trial design, site selection, clinical development and translational research.